Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 28 October 2003
Vol. 2003, Issue 206, p. tw423
[DOI: 10.1126/stke.2003.206.tw423]

EDITORS' CHOICE

STEROIDS A New Estrogenic Pathway

Although estrogens have classically been believed to act through nuclear receptors that function as transcription factors, it has become increasingly apparent that, as with other steroid hormones, rapid effects of estrogens can be initiated at the plasma membrane. The receptors and pathways through which these peripheral effects are mediated, however, remain unclear. Qiu et al. investigated modulation of {gamma}-aminobutyric acid (GABA)-mediated activation of heterotrimeric guanosine triphosphate-binding protein-coupled inwardly rectifying K+ (GIRK) channels by 17β-estradiol (E2) in hypothalamic neurons. They identified a signaling pathway that involved activation of Gαq after E2 binding to a transmembrane estrogen receptor. The authors used whole-cell recordings of GABA-, proopiomelanocortin-, and dopamine-expressing neurons in hypothalamic slices from ovariectomized guinea pigs to investigate the effects of E2 and various selective estrogen receptor modulators (SERMs) on GIRK activation by the GABAB receptor agonist baclofen. E2 inhibited baclofen-mediated GIRK activation, as did raloxifene, STX (a SERM without activity at nuclear estrogen receptors), and membrane-impermeant E2 bound to bovine serum albumen, whereas tamoxifen did not. Pharmacological analysis indicated that this effect of E2 involved protein kinase C {delta} acting upstream of protein kinase A, but not mitogen-activated protein kinase pathways. The authors used a peptide inhibitor to implicate Gαq in this signaling pathway. These data extend the mechanisms whereby estrogens are known to act within the central nervous system; moreover, the identification of STX as selective for this pathway may facilitate the development of highly specific approaches to estrogen therapy.

J. Qiu, M. A. Bosch, S. C. Tobias, D. K. Grandy, T. S. Scanlan, O. K. Rønnekleiv, M. J. Kelly, Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C. J. Neurosci 23, 9529-9540 (2003). [Abstract] [Full Text]

Citation: A New Estrogenic Pathway. Sci. STKE 2003, tw423 (2003).



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882